Pethidine Analgesia and Neonatal Hearing Screening Test

Study Overview
=================
Brief Summary
-----------------
Neonatal hearing screening may fail due to some perinatal and neonatal factors. It is well known that false positivity in newborn hearing screening increases cost and maternal anxiety and anxiety. There is still widespread concern about the use of opoid analgesics to relieve pain during labor. The aim of this study was to determine the effects of pethidine administered during labor on neonatal hearing screening test false positivity rates.

Detailed Description
-----------------
The study group consisted of patients receiving 50 mg intramuscular (I.M) pethidine at the beginning of the active phase of labor and the control group consisted of patients not receiving pethidine. Newborns were evaluated by otoacoustic emission (OAE) test. The OAE test was performed before the patients were discharged. Perinatal and neonatal variables and test results were recorded and the relationship between false positivity and pethidine use was evaluated.

Official Title
-----------------
Effect of Pethidine Analgesia on False Positivity in Neonatal Hearing Screening Test

Conditions
-----------------
Hearing Loss, Newborn Complication

Intervention / Treatment
-----------------
* Diagnostic Test: Neonatal Hearing Screening Test


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: term singleton pregnancy, Gave birth at 37-41 weeks of gestation, without chronic internal disease, Pregnant women were included in the study. Exclusion Criteria: Newborn hospitalized in intensive care, congenital / chromosomal anomaly, congenital CMV infection, facial / ear deformities, family with hearing problems, those with hyperbilirunemia, tested at <12 hours after birth, maternal infection, Diabetes mellitus, recurrent abortion, smoking, plesanta previa, prolonged premature rupture of the membrane (more than 12 hours), epidural -analgesia and newborns who were at risk of asphyxia hypoxia were excluded from the study.

Ages Eligible for Study
-----------------
Minimum Age: 24 Hours
Maximum Age: 14 Days

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| study group<br>The results of the hearing screening test of the beats of the patients who have undergone pethidine in the active phase of labor will be examined. the results will be reported as passed - remained; the false positivity rate according to the retest of the remaining group is to be looked at. | Diagnostic Test: Neonatal Hearing Screening Test<br>* neonatal hearing screening test results will be evaluated.<br>|
| control group<br>In the active phase of labor, hearing screening test results of beats of pediatric patients will be evaluated. the results will be reported as passed - remained; the false positivity rate according to the retest of the remaining group is to be looked at. control group. | Diagnostic Test: Neonatal Hearing Screening Test<br>* neonatal hearing screening test results will be evaluated.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Neonatal Hearing Screening Test | neonatal hearing screening test results will be evaluated. will be reported as left or passed. The pass'' en response observed in the hearing screening device indicates that the baby passed the screening test, and the refer response indicates that the baby has failed. | 2 week | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Newborn Hearing Screening, Otoacoustic emissions, Pethidine, False positive